356 related articles for article (PubMed ID: 33939118)
1. Targeting AMPK by Statins: A Potential Therapeutic Approach.
Dehnavi S; Kiani A; Sadeghi M; Biregani AF; Banach M; Atkin SL; Jamialahmadi T; Sahebkar A
Drugs; 2021 Jun; 81(8):923-933. PubMed ID: 33939118
[TBL] [Abstract][Full Text] [Related]
2. Combined cancer therapy with non-conventional drugs: all roads lead to AMPK.
Chen S; Zhu X; Lai X; Xiao T; Wen A; Zhang J
Mini Rev Med Chem; 2014; 14(8):642-54. PubMed ID: 25138094
[TBL] [Abstract][Full Text] [Related]
3. Mevastatin promotes neuronal survival against Aβ-induced neurotoxicity through AMPK activation.
Kornelius E; Li HH; Peng CH; Hsiao HW; Yang YS; Huang CN; Lin CL
Metab Brain Dis; 2017 Dec; 32(6):1999-2007. PubMed ID: 28840430
[TBL] [Abstract][Full Text] [Related]
4. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
5. AMPK and vasculoprotection.
Ewart MA; Kennedy S
Pharmacol Ther; 2011 Aug; 131(2):242-53. PubMed ID: 21111758
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic use of Statins as non-lipid-lowering drugs.
Zhang Q; Dong J; Yu Z
Int J Biol Sci; 2020; 16(14):2704-2711. PubMed ID: 33110390
[TBL] [Abstract][Full Text] [Related]
7. SGLT2 inhibitors and AMPK: The road to cellular housekeeping?
Safaie N; Masoumi S; Alizadeh S; Mirzajanzadeh P; Nejabati HR; Hajiabbasi M; Alivirdiloo V; Basmenji NC; Derakhshi Radvar A; Majidi Z; Faridvand Y
Cell Biochem Funct; 2024 Jan; 42(1):e3922. PubMed ID: 38269506
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds.
Marín-Aguilar F; Pavillard LE; Giampieri F; Bullón P; Cordero MD
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146060
[No Abstract] [Full Text] [Related]
9. Statins activate AMP-activated protein kinase in vitro and in vivo.
Sun W; Lee TS; Zhu M; Gu C; Wang Y; Zhu Y; Shyy JY
Circulation; 2006 Dec; 114(24):2655-62. PubMed ID: 17116771
[TBL] [Abstract][Full Text] [Related]
10. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of statins on the autophagy: A therapeutic perspective.
Ashrafizadeh M; Ahmadi Z; Farkhondeh T; Samarghandian S
J Cell Physiol; 2020 Apr; 235(4):3157-3168. PubMed ID: 31578730
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells.
Ma L; Niknejad N; Gorn-Hondermann I; Dayekh K; Dimitroulakos J
PLoS One; 2012; 7(9):e46055. PubMed ID: 23029387
[TBL] [Abstract][Full Text] [Related]
13. Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions.
Tajbakhsh A; Gheibihayat SM; Askari H; Savardashtaki A; Pirro M; Johnston TP; Sahebkar A
Pharmacol Ther; 2022 Oct; 238():108282. PubMed ID: 36130624
[TBL] [Abstract][Full Text] [Related]
14. Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function.
Haslinger-Löffler B
Kidney Int; 2008 Sep; 74(5):553-5. PubMed ID: 18709024
[TBL] [Abstract][Full Text] [Related]
15. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
16. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
[TBL] [Abstract][Full Text] [Related]
17. 5'-Adenosine monophosphate-activated protein kinase: A potential target for disease prevention by curcumin.
Soltani A; Salmaninejad A; Jalili-Nik M; Soleimani A; Javid H; Hashemy SI; Sahebkar A
J Cell Physiol; 2019 Mar; 234(3):2241-2251. PubMed ID: 30146757
[TBL] [Abstract][Full Text] [Related]
18. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
[TBL] [Abstract][Full Text] [Related]
20. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
